Citation Impact

Citing Papers

A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer
1991
Establishing the Diagnosis of Lung Cancer
2013 Standout
Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients
2013
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients
2013
Prosthetic-Joint Infections
2004 Standout
Treatment of Malignant Pleural Effusions with Doxorubicin Hydrochloride-Containing Poly(L-Lactic Acid) Microspheres
1991
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
BTS guidelines for the management of pleural infection in children
2005 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Histologic Changes of Doxycycline Pleurodesis in Rabbits
1994
Spontaneous Pneumothorax
2000 Standout
Radionuclide imaging in orthopedic infections
1997
Spontaneous Pneumothorax
1994
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
2004
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
2010 Standout
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Effect of Patient Positioning on Distribution of Tetracycline in the Pleural Space during Pleurodesis
1988
The evidence on the effectiveness of management for malignant pleural effusion: a systematic review
2006
Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin
1997
Comparison of the Effectiveness of Tetracycline and Minocycline as Pleural Sclerosing Agents in Rabbits
1994
Diabetic Foot Disorders: A Clinical Practice Guideline (2006 Revision)
2006 Standout
Management of malignant pleural effusions
2001 Standout
The Pleura
1988 Standout
Functional imaging and the orthopaedic surgeon
2002
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Malignant Pleural Effusions
1985
Chest Tubes
1987
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Thoracoscopy under regional anesthesia for the diagnosis and management of pleural disease
1987
Interventions for treating oral mucositis for patients with cancer receiving treatment
2010
Bleomycin and tetracycline in malignant pleural effusions: a review.
1992
Indium-111-labeled leukocytes for the detection of infection: Current status
1994
Prosthetic Joint Infection
2014 Standout
Intrapleural Chemotherapy Without Pleurodesis for Malignant Pleural Effusions
1994
Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Diagnosis of Infection following Total Hip Arthroplasty*†
1997
Pleural Fluid pH in Malignant Effusions
1988
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout

Works of S. Oswald being referenced

Three-phase bone scan and indium white blood cell scintigraphy following porous coated hip arthroplasty: a prospective study of the prosthetic tip.
1989
Intrapleural tetracycline in malignant pleural effusions: A randomized study
1983
Treatment of Radiation‐ and Chemotherapy‐Induced Stomatitis
1990
Rankless by CCL
2026